Skip to content

The correlation between coronary microvascular disease and cerebral small vessel disease: a prospective cohort study

The correlation between coronary microvascular disease and cerebral small vessel disease: a prospective cohort study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091577
Enrollment
Unknown
Registered
2024-10-30
Start date
2024-10-30
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary microvascular disease

Interventions

Non-microcirculatory disorder group:None
Microcirculatory disorder group:None

Sponsors

Beijing Anzhen Hosptial, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Aged 18-80, regardless of gender, with autonomous behavior capacity; 2: Clinical preliminary diagnosis of coronary heart disease, planned to undergo coronary angiography; 3: Written informed consent can be provided.

Exclusion criteria

Exclusion criteria: 1: Patients after pacemaker surgery and implanted drug pumps 2: Metal implants such as steel plates and nails in the torso 3: Patients with claustrophobia who cannot lie still in a closed environment 4: Severe chest deformity 5: Old myocardial infarction 6: Contraindications of cranial MRI examination 7: Subjects deemed unsuitable for inclusion by the investigator for other reasons

Design outcomes

Primary

MeasureTime frame
caIMR;Differences in the prevalence of cerebral small vessel disease;

Secondary

MeasureTime frame
Differences in cognitive function;Differences in lipidomics metabolite composition categories and proportional ;

Countries

China

Contacts

Public ContactSongxiantao

Beijing Anzhen Hosptial, Capital Medical University

tcc2033@163.com+86 152 0164 8899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026